Catalina Research Institute, LLC is a fast growing, multi-specialty research site in Montclair, California. Catalina Research Institute is a premier clinical trials center focused on solving medical problems that are important to our community.
The ENLIGHTEN Fibrosis study is a phase 3 clinical trial for people with fatty liver disease, otherwise known as MASH/NASH, studying the effectiveness and safety of the study medication, pegozafermin. This study is for people [age range specified in latest protocol] who have been confirmed to have MASH/NASH with fibrosis. Together, we aim to provide a potential treatment and improve the lives of people living with MASH/NASH.
How do I know if I can join the ENLIGHTEN Fibrosis study?
You may be able to join the study if you meet the following requirements:
18-75 years old
Willing to undergo a biopsy of the liver to confirm MASH/NASH and again after 12 months and 36 months of treatment
Confirmed diagnosis of MASH/NASH with F2 or F3 Fibrosis
Other study requirements will apply
Participation in the ENLIGHTEN Fibrosis study will last a minimum of 40 months (about 3 and a half years).
Call to see if you may qualify (909) 590-8409.
Business hours Monday- Friday 7am-4pm
Catalina Research Institute
9525 Monte Vista Ave, Suite 200
Montclair, CA 91763
